EFX
30
-8
EW
32
3
BEN
50
9
AXP
67
-2
SBUX
37
-2
HCA
48
-2
WDC
37
-3
TDC
67
-4
KHC
9
-4
CRM
60
-7
CVS
41
-4
AAP
35
-9
WHR
65
-5
R
70
-3
CNX
73
-3
IRM
41
3
MAS
52
-4
AMT
37
3
GRMN
67
-4
KMX
61
-3
EFX
30
-8
EW
32
3
BEN
50
9
AXP
67
-2
SBUX
37
-2
HCA
48
-2
WDC
37
-3
TDC
67
-4
KHC
9
-4
CRM
60
-7
CVS
41
-4
AAP
35
-9
WHR
65
-5
R
70
-3
CNX
73
-3
IRM
41
3
MAS
52
-4
AMT
37
3
GRMN
67
-4
KMX
61
-3
Financhill
Back

BNY Mellon Emerging Markets Equity ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
52

BKEM
BNY Mellon Emerging Markets Equity ETF

Last Price:
59.34
Seasonality Move:
7.33%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
52
BNY Mellon Emerging Markets Equity ETF (BKEM) is a Buy

Is BNY Mellon Emerging Markets Equity ETF a Buy, Sell or Hold?

  • The current BNY Mellon Emerging Markets Equity ETF [BKEM] share price is $59.37. The Score for BKEM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BKEM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKEM Stock Price Chart

What is BNY Mellon Emerging Markets Equity ETF's stock price today?

  • The BNY Mellon Emerging Markets Equity ETF share price today is $59.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BKEM is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BKEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.75 Sell
Relative Strength Index (14 RSI): 34.28 Sell
Chaikin Money Flow: -1740 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.75 - 63.13) Sell
Bollinger Bands (100): (59.08 - 63) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

BKEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.79 Sell
20-day SMA: 61.65 Sell
50-day SMA: 62.25 Sell
200-day SMA: 59.42 Sell
8-day EMA: 60.44 Sell
20-day EMA: 61.39 Sell
50-day EMA: 61.71 Sell
200-day EMA: 59.65 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

BNY Mellon Emerging Markets Equity ETF Earnings Growth & BKEM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

BNY Mellon Emerging Markets Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):